Selank

Clinical Trials

Cognitive Enhancement

A synthetic peptide analog of tuftsin with anxiolytic and nootropic properties that enhances cognitive function without sedation.

Administration

Intranasal spray

Dosage Range

250-500 mcg daily

Mechanism of Action

Selank modulates the expression of BDNF (brain-derived neurotrophic factor), influences serotonin metabolism, and stabilizes enkephalins in the blood, producing anxiolytic effects without sedation or addiction potential.

Clinical Benefits

Reduces anxiety without sedation

Enhances memory and learning

Improves focus and concentration

Stabilizes mood

Immunomodulatory effects

Clinical Evidence

Approved in Russia as an anxiolytic medication. Clinical studies demonstrate significant anxiety reduction comparable to benzodiazepines without cognitive impairment or dependence risk.

Side Effects

Mild nasal irritation

Fatigue (rare)

Headache (rare)

Contraindications

Pregnancy

Breastfeeding

Severe liver disease

Related Peptides in Cognitive Enhancement

Semax

A synthetic ACTH analog that enhances cognitive function, provides neuroprotection, and supports brain recovery from injury.

Dihexa

An angiotensin IV analog with extraordinary potency for cognitive enhancement, being 10 million times more potent than BDNF at promoting neuronal connections.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapy should only be administered under the supervision of a qualified healthcare provider. Always consult your physician before starting any new treatment protocol.